Isolated IgG4-related Infundibulo-hypophysitis.

JCEM case reports Pub Date : 2024-10-16 eCollection Date: 2024-10-01 DOI:10.1210/jcemcr/luae182
Margaret E Allen, Ryan T Beck, Nathan T Zwagerman, Dylan Coss, Amy Fisco, Adriana G Ioachimescu
{"title":"Isolated IgG4-related Infundibulo-hypophysitis.","authors":"Margaret E Allen, Ryan T Beck, Nathan T Zwagerman, Dylan Coss, Amy Fisco, Adriana G Ioachimescu","doi":"10.1210/jcemcr/luae182","DOIUrl":null,"url":null,"abstract":"<p><p>A 72-year-old man presented with several months of weakness, poor appetite, and depressed moods. Laboratory tests indicated central hypocortisolism, hypothyroidism and hypogonadism, and mild hyperprolactinemia. Imaging indicated a homogenously enhancing solid suprasellar mass inseparable from the hypothalamus and contiguous with a thickened proximal infundibulum. Neuro-ophthalmological evaluation was normal. Symptoms improved with hydrocortisone, levothyroxine, and testosterone replacement. After 6 months, transsphenoidal biopsy was performed due to mass enlargement and revealed fibrosis, lymphoplasmacytic infiltration, and CD138 and IgG4 staining. The levels of serum IgG4, complement, inflammatory markers, protein electrophoresis, amylase, and lipase and imaging of the chest, abdomen, and thyroid were unremarkable. After 1 month of prednisone therapy (starting dose 40 mg/day), the mass significantly involuted and remained stable afterward. Prednisone was gradually tapered to 5 mg daily over 10 weeks. During 22 months of follow-up, no systemic IgG4 disease was detected. Glucocorticoid, thyroid, and testosterone replacement was continued. This case of isolated IgG4-related hypophysitis illustrates the variable presentation that may not entail vasopressin deficiency or clinical mass effect. This entity should be considered in the differential diagnosis of suprasellar masses even in the absence of IgG4 systemic disease or characteristic serology. Management entails multidisciplinary collaboration and long-term follow-up.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 10","pages":"luae182"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11482006/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCEM case reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/jcemcr/luae182","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A 72-year-old man presented with several months of weakness, poor appetite, and depressed moods. Laboratory tests indicated central hypocortisolism, hypothyroidism and hypogonadism, and mild hyperprolactinemia. Imaging indicated a homogenously enhancing solid suprasellar mass inseparable from the hypothalamus and contiguous with a thickened proximal infundibulum. Neuro-ophthalmological evaluation was normal. Symptoms improved with hydrocortisone, levothyroxine, and testosterone replacement. After 6 months, transsphenoidal biopsy was performed due to mass enlargement and revealed fibrosis, lymphoplasmacytic infiltration, and CD138 and IgG4 staining. The levels of serum IgG4, complement, inflammatory markers, protein electrophoresis, amylase, and lipase and imaging of the chest, abdomen, and thyroid were unremarkable. After 1 month of prednisone therapy (starting dose 40 mg/day), the mass significantly involuted and remained stable afterward. Prednisone was gradually tapered to 5 mg daily over 10 weeks. During 22 months of follow-up, no systemic IgG4 disease was detected. Glucocorticoid, thyroid, and testosterone replacement was continued. This case of isolated IgG4-related hypophysitis illustrates the variable presentation that may not entail vasopressin deficiency or clinical mass effect. This entity should be considered in the differential diagnosis of suprasellar masses even in the absence of IgG4 systemic disease or characteristic serology. Management entails multidisciplinary collaboration and long-term follow-up.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
与 IgG4 相关的孤立性 Infundibulo-hypophysitis.
一名 72 岁的男子数月来身体虚弱、食欲不振、情绪低落。实验室检查显示他患有中枢性皮质醇增多症、甲状腺功能减退症和性腺功能减退症,以及轻度高泌乳素血症。影像学检查显示,与下丘脑密不可分的鞍上肿块呈均匀强化的实性肿块,与增厚的近基底相邻。神经眼科评估结果正常。使用氢化可的松、左甲状腺素和睾酮替代物后,症状有所改善。6 个月后,由于肿块增大,患者接受了经鼻活检,结果显示肿瘤纤维化、淋巴浆细胞浸润、CD138 和 IgG4 染色。血清 IgG4、补体、炎症标志物、蛋白电泳、淀粉酶和脂肪酶水平以及胸部、腹部和甲状腺影像学检查均无异常。泼尼松治疗(起始剂量为 40 毫克/天)1 个月后,肿块明显缩小,之后一直保持稳定。泼尼松在10周内逐渐减量至每天5毫克。在 22 个月的随访中,未发现系统性 IgG4 疾病。糖皮质激素、甲状腺素和睾酮替代治疗仍在继续。这例孤立的 IgG4 相关性肾上腺皮质功能减退症说明,该病的表现多种多样,可能不伴有血管加压素缺乏或临床肿块效应。即使没有 IgG4 系统性疾病或特征性血清学检查,在鉴别诊断鞍上肿块时也应考虑到这一实体。治疗需要多学科协作和长期随访。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Empagliflozin-induced Myopathy. Severe, Symptomatic Hypercalcemia Secondary to PTH-secreting Pancreatoblastoma. A Case of Enfortumab Vedotin-Associated Diabetic Ketoacidosis With Severe Insulin Resistance in a Nondiabetic Woman. Acquired 11β-hydroxylase Deficiency by Inhaled Etomidate and its Analogues: A Mimic of Congenital Adrenal Hyperplasia. Aldosterone-producing Multiple Micronodules With Several Different KCNJ5 Pathogenic Variants.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1